Cathay Biotech Inc.
Chemicals · Basic Materials
CFO
1 appearance
Latest appearance 2025-05-15
杨温颖
CFO
Cathay Biotech Inc.
Equibles does not estimate personal net worth.
About 杨温颖
杨温颖 is recorded as CFO at Cathay Biotech Inc.. 杨温颖 has spoken on 1 earnings call across 1 company, most recently for Cathay Biotech Inc. on May 15, 2025. Cathay Biotech Inc. is classified in the Chemicals industry within the Basic Materials sector.
杨温颖 on recent calls
“对公司2024年和2025年一季度的经营业绩情况如下说明 卡塞生物2024年和2025年一季度的主要财务业绩表现如下 2024年全年公司实现营业收入29. 58亿元 同比增长39. 91% 研发投入2. 33亿元 同比增长23. 38% 归属于上市公司股东的净利润4. 89亿元 同比增长33. 41% 基本每股收益0.”
Affiliation history
-
Cathay Biotech Inc.
CFO
Transcript header (unverified)
Current
Company network
Recent activity
-
Earnings call
凯赛生物2024年度暨2025第一季度业绩说明会
Cathay Biotech Inc.